BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 246 filers reported holding BIO-TECHNE CORP in Q3 2015. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,144,000 | +33.5% | 25,645 | +4.2% | 0.02% | +14.3% |
| Q3 2020 | $6,099,000 | -6.4% | 24,620 | -0.2% | 0.02% | -12.5% |
| Q2 2020 | $6,514,000 | +70.9% | 24,666 | +22.7% | 0.02% | +41.2% |
| Q1 2020 | $3,812,000 | +13.8% | 20,102 | +31.7% | 0.02% | +41.7% |
| Q4 2019 | $3,349,000 | +13.7% | 15,258 | +1.4% | 0.01% | 0.0% |
| Q3 2019 | $2,946,000 | -15.1% | 15,054 | -9.5% | 0.01% | -14.3% |
| Q2 2019 | $3,469,000 | +6.8% | 16,638 | +1.7% | 0.01% | 0.0% |
| Q1 2019 | $3,249,000 | +15.9% | 16,367 | -15.5% | 0.01% | 0.0% |
| Q4 2018 | $2,803,000 | -61.5% | 19,371 | -45.7% | 0.01% | -56.2% |
| Q3 2018 | $7,281,000 | +36.3% | 35,670 | -1.2% | 0.03% | +23.1% |
| Q2 2018 | $5,342,000 | +0.5% | 36,108 | +2.7% | 0.03% | 0.0% |
| Q1 2018 | $5,313,000 | +31.1% | 35,174 | +12.4% | 0.03% | +23.8% |
| Q4 2017 | $4,054,000 | +11.5% | 31,290 | +4.0% | 0.02% | 0.0% |
| Q3 2017 | $3,636,000 | +11.5% | 30,077 | +8.4% | 0.02% | +5.0% |
| Q2 2017 | $3,262,000 | +11.0% | 27,758 | -4.0% | 0.02% | 0.0% |
| Q1 2017 | $2,940,000 | -3.1% | 28,920 | -2.0% | 0.02% | -13.0% |
| Q4 2016 | $3,033,000 | -40.5% | 29,499 | -36.7% | 0.02% | -37.8% |
| Q3 2016 | $5,101,000 | +218.6% | 46,582 | +228.2% | 0.04% | +184.6% |
| Q2 2016 | $1,601,000 | +99.1% | 14,193 | +66.8% | 0.01% | +85.7% |
| Q1 2016 | $804,000 | +0.2% | 8,510 | -4.5% | 0.01% | 0.0% |
| Q4 2015 | $802,000 | -10.2% | 8,908 | -7.8% | 0.01% | -22.2% |
| Q3 2015 | $893,000 | -6.3% | 9,661 | -0.2% | 0.01% | -10.0% |
| Q2 2015 | $953,000 | -0.2% | 9,683 | +1.6% | 0.01% | -9.1% |
| Q1 2015 | $955,000 | +3.2% | 9,526 | -4.9% | 0.01% | 0.0% |
| Q4 2014 | $925,000 | – | 10,012 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ownership Capital B.V. | 972,263 | $308,742,000 | 4.35% |
| Sandhill Capital Partners LLC | 138,864 | $44,096,000 | 4.03% |
| STONE RUN CAPITAL, LLC | 27,350 | $8,685,000 | 3.45% |
| DF DENT & CO INC | 925,823 | $293,995,000 | 3.42% |
| Brown Capital Management | 1,498,233 | $475,764,000 | 3.29% |
| MAIRS & POWER INC | 848,081 | $269,308,000 | 2.99% |
| Summit Creek Advisors LLC | 64,179 | $20,380,000 | 2.62% |
| GENEVA CAPITAL MANAGEMENT LLC | 402,958 | $127,959,000 | 2.17% |
| Aristotle Atlantic Partners, LLC | 86,993 | $27,625,000 | 2.13% |
| CROWN ADVISORS MANAGEMENT, INC. | 8,000 | $2,540,000 | 1.82% |